Publikationen von C. Monnerjahn

Lavie, A.; Su, Y.; Ghassemi, M.; Novak, R. M.; Caffrey, M.; Sekulic, N.; Monnerjahn, C.; Konrad, M.; Cook, J. L.: Restoration of the antiviral activity of 3'-azido-3'-deoxythymidine (AZT) against AZT-resistant human immunodeficiency virus by delivery of engineered thymidylate kinase to T cells. Journal of General Virology 89 (7), S. 1672 - 1679 (2008)

Segura-Pena, D.; Lutz, S.; Monnerjahn, C.; Konrad, M.; Lavie, A.: Binding of ATP to TK1-like enzymes is associated with a conformational change in the quaternary structure. Journal of Molecular Biology 369 (1), S. 129 - 141 (2007)

Gardberg, A.; Shuvalova, L.; Monnerjahn, C.; Konrad, M.; Lavie, A.: Structural basis for the dual thymidine and thymidylate kinase activity of herpes thymidine kinases. Structure 11 (10), S. 1265 - 1277 (2003)

Sabini, E.; Ort, S.; Monnerjahn, C.; Konrad, M.; Lavie, A.: Structure of human dCK suggests strategies to improve anticancer and antiviral therapy. Nature Structural Biology 10 (7), S. 513 - 519 (2003)

Ostermann, N.; Segura-Pena, D.; Meier, C.; Veit, T.; Monnerjahn, C.; Konrad, M.; Lavie, A.: Structures of human thymidylate kinase in complex with prodrugs: Implications for the structure-based design of novel compounds. Biochemistry 42 (9), S. 2568 - 2577 (2003)

Monnerjahn, C.; Konrad, M.: Modulated nucleoside kinases as tools to improve the activation of therapeutic nucleoside analogues. ChemBioChem 4 (2-3), S. 143 - 146 (2003)

Konrad, M.; Ort, S.; Monnerjahn, C.; Lavie, A.: Engineering of nucleoside kinases to improve the activation of nucleoside analog prodrugs. FEBS Journal 273 (Suppl. 1), S. 50 - 50 (2006)